Cystic fibrosis gene mutation (deltaF508) is associated with an intrinsic abnormality in Ca2+-induced arachidonic acid release by epithelial cells. [electronic resource]
Producer: 19970725Description: 749-59 p. digitalISSN:- 1044-5498
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Arachidonic Acid -- antagonists & inhibitors
- Calcimycin -- pharmacology
- Calcium -- metabolism
- Cells, Cultured
- Chlorides -- metabolism
- Cystic Fibrosis -- drug therapy
- Cystic Fibrosis Transmembrane Conductance Regulator -- genetics
- Dose-Response Relationship, Drug
- Epithelial Cells
- Epithelium -- metabolism
- Humans
- Ibuprofen -- administration & dosage
- Lipoprotein Lipase -- antagonists & inhibitors
- Mutation
- Phospholipases A -- antagonists & inhibitors
- Phospholipases A2
- Precipitin Tests
- Staurosporine -- pharmacology
- Tetradecanoylphorbol Acetate -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.